Journal: British journal of haematology
Article Title: The BTK Inhibitor Ibrutinib (PCI-32765) Blocks Hairy Cell Leukaemia Survival, Proliferation and BCR Signalling: A New Therapeutic Approach
doi: 10.1111/bjh.12867
Figure Lengend Snippet: Upon antigen stimulation, BCR signalling induces LYN and SYK phosphorylation (P in orange circles refer to phosphorylation) that initiate a signalling cascade causing downstream BTK activation. BTK is recruited into the signalling complex at the plasma membrane via the docking of its pleckstrin homology domain to phosphatidylinositol 3,4,5 triphosphate (PIP3). BTK becomes phosphorylated and therefore induces calcium release, which initiates a signalling cascade with the consequent induction of cell proliferation and survival. BTK is also involved in signalling of chemokine receptor CXCR4, which is important in cell migration and could be a suitable target for ibrutinib.
Article Snippet: Flow cytometric analysis was done on HCL cell suspensions (ESKOL, HC-1 and primary HCL cells: HCL1 to HCL7 and HCL9 to HCL14) stained with phycoerythrin (PE)-conjugated mouse anti-human CD184 (CXCR4), allophycocyanin (APC)-conjugated mouse anti-human CD19, and isotype control PE-conjugated mouse IgG2a,κ (BD Pharmingen).
Techniques: Activation Assay, Migration